跳至主要内容
临床试验/ACTRN12611000809932
ACTRN12611000809932尚未招募未知

Analysis of the effectiveness in clinical practice of the use of polymethylmethacrylate membrane dialyzer as adjuvant in the treatment of dialysis patients in the course of Hepatitis B vaccination

SL 8 Arezzo P.O. Ospedale S. Donato di Arezzo0 个研究点目标入组 40 人开始时间: 2011年8月2日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • End Stage Renal desease patients on mainteinance thrice-weekly dialysis treatment who had been defined as non-responder to Hepatitis B vaccination according to CDC criteria

排除标准

  • End Stage Renal desease patients on mainteinance thrice-weekly dialysis treatment who had been defined as non responder to Hepatitis B vaccination according to CDC criteria already using any kind of polymethylmethacrylate membrane dialyzers at the initial time of observation

研究者

发起方
SL 8 Arezzo P.O. Ospedale S. Donato di Arezzo

相似试验